Psyched: MindMed’s Nasdaq Debut, PharmaDrug Gets Orphan Drug Designation For DMT, Numinus Launches Clinical Trial Of Naturally Derived Psilocybin,

PharmaDrug Inc. (CSE:BUZZ) (OTC:LMLLF) announced an FDA-granted Orphan Drug Designation to its wholly owned subsidiary Sairiyo Therapeutics Inc., for the use of DMT in organ transplantations. When …, PharmaDrug Inc. (CSE:BUZZ) (OTC:LMLLF) announced an FDA-granted Orphan Drug Designation to its wholly owned subsidiary Sairiyo Therapeutics Inc., for the use of DMT in organ transplantations. When …, Read More

Scroll to Top